Search results for " esophagus"

showing 10 items of 63 documents

Management of pre-malignant and malignant lesions by endoscopic resection

2003

Endoscopic resection (ER) has gained more and more importance in the treatment of early gastrointestinal neoplasia over the last few years. The choice of the different available techniques depends on the site, the macroscopic type of the tumour and the personal experience of the endoscopist. The 'suck-and-cut' technique with ligation device or cap should be favoured to normal strip biopsy in the oesophagus because of the size of the resected specimen and its technical feasibility. A recently described method of ER in the stomach is the circumferential mucosal incision with a type of needle-knife and subsequent en-bloc resection following prior injection under the lesions. ER of high-grade i…

Malemedicine.medical_specialtyEsophageal NeoplasmsColorectal cancerEndoscopic mucosal resectionRisk AssessmentBarrett EsophagusStomach NeoplasmsmedicineHumansMinimally Invasive Surgical ProceduresGastrointestinal NeoplasmsNeoplasm StagingClinical Trials as TopicIntraepithelial neoplasiamedicine.diagnostic_testbusiness.industryStomachBiopsy NeedleGastroenterologyEndoscopymedicine.diseaseImmunohistochemistrydigestive system diseasesEndoscopySurgeryMajor duodenal papillaTreatment Outcomemedicine.anatomical_structureAdenocarcinomaFemaleLigationbusinessPrecancerous ConditionsFollow-Up StudiesBest Practice & Research Clinical Gastroenterology
researchProduct

Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus.

2008

Background & Aims: The aim of this study was to compare magnified still images obtained with high-resolution white light endoscopy, indigo carmine chromoendoscopy, acetic acid chromoendoscopy, and narrow-band imaging to determine the best technique for use in Barrett's esophagus. Methods: We obtained magnified images from 22 areas with the 4 aforementioned techniques. Seven endoscopists with no specific expertise in Barretes esophagus or advanced imaging techniques and 5 international experts in this field evaluated these 22 areas for overall image quality, mucosal image quality, and vascular image quality. In addition, the regularity of mucosal and vascular patterns and the presence of abn…

Malemedicine.medical_specialtyEsophageal NeoplasmsHigh resolutionIndigo CarmineGastroenterologyChromoendoscopychemistry.chemical_compoundBarrett EsophagusEsophagusInternal medicinemedicineHumansEsophagusColoring AgentsAcetic AcidAgedAged 80 and overObserver VariationNarrow-band imagingMucous MembraneHepatologybusiness.industryGastroenterologyReproducibility of ResultsMiddle Agedmedicine.diseaseImage EnhancementMagnification endoscopymedicine.anatomical_structureIndigo carminechemistryBarrett's esophagusHigh Grade Intraepithelial NeoplasiaFemaleEsophagoscopyNuclear medicinebusinessPrecancerous ConditionsGastroenterology
researchProduct

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

2019

Contains fulltext : 215282.pdf (Publisher’s version ) (Closed access) BACKGROUND & AIMS: Epidemiology studies of circulating concentrations of 25 hydroxy vitamin D (25(OH)D) and risk of esophageal adenocarcinoma (EAC) have produced conflicting results. We conducted a Mendelian randomization study to determine the associations between circulating concentrations of 25(OH)D and risks of EAC and its precursor, Barrett's esophagus (BE). METHODS: We conducted a Mendelian randomization study using a 2-sample (summary data) approach. Six single-nucleotide polymorphisms (SNPs; rs3755967, rs10741657, rs12785878, rs10745742, rs8018720, and rs17216707) associated with circulating concentrations of 25(O…

Malemedicine.medical_specialtyEsophageal NeoplasmsMedizinSingle-nucleotide polymorphismAdenocarcinomaGastroenterologyPolymorphism Single NucleotideRisk AssessmentArticleBarrett EsophagusRisk FactorsInternal medicineMendelian randomizationEpidemiologymedicineVitamin D and neurologyBiomarkers TumorSNPHumansVitamin DHepatologybusiness.industryGastroenterologyOdds ratioDNA NeoplasmEsophageal cancerMendelian Randomization Analysismedicine.diseaseEuropeRenal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11]Barrett's esophagusNorth AmericaFemaleMorbiditybusinessClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
researchProduct

Conclusions from the histological diagnosis of low-grade intraepithelial neoplasia in Barrett's oesophagus.

2007

It is well known that low-grade intraepithelial neoplasia (LGIN) in Barrett's oesophagus (BE) might progress to high-grade intraepithelial neoplasia (HGIN) or carcinoma. Since accurate diagnosis of LGIN is difficult, general pathologists are frequently uncertain about the diagnosis of LGIN and its follow-up risks. The purpose of this study was to analyse the divergence between the diagnoses of general and specialized gastrointestinal pathologists.Fifty consecutive patients with a previous diagnosis of LGIN in BE, made by a general pathologist, were included in our study. The histopathological slides of every patient were reassessed in a blinded fashion by two specialized gastrointestinal (G…

Malemedicine.medical_specialtyGastroenterologyBarrett EsophagusInternal medicineMetaplasiamedicineCarcinomaHumansMedical diagnosisLow Grade Intraepithelial NeoplasiaAgedIntraepithelial neoplasiamedicine.diagnostic_testEsophageal diseasebusiness.industryGastroenterologyMiddle Agedmedicine.diseasedigestive system diseasesEndoscopysurgical procedures operativeHistopathologyFemalemedicine.symptombusinessCarcinoma in SituFollow-Up StudiesScandinavian journal of gastroenterology
researchProduct

Expression of α-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett’s esophagus

2008

Two different studies demonstrated alpha-methylacyl coenzyme A racemase (AMACR) to be a highly specific marker in Barrett's neoplastic lesions. Reactive atypia was positive in 3/30 cases in these studies. We present a retrospective study of early Barrett's adenocarcinoma treated with surgery (2000-2005, n=29; M:F=5:1, median age 67 years). We analyzed the role of AMACR expression in reactive and neoplastic lesions associated with the disease of 77 different specimens (60 biopsy and 17 surgical specimens) of these patients. In our cohort, 70% of cases demonstrated infiltration of the submucosa, 38% were poorly differentiated, and/or 31% demonstrated lymph vessel infiltration. We used a multi…

Malemedicine.medical_specialtyPathologyColumnar epithelial cellEsophageal NeoplasmsRacemases and EpimerasesAdenocarcinomaBiologyGastroenterologyPathology and Forensic MedicineBarrett EsophagusSubmucosaInternal medicineBiopsyBiomarkers TumormedicineAtypiaCarcinomaHumansAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testMiddle Agedmedicine.diseasedigestive system diseasesmedicine.anatomical_structureTissue Array AnalysisDysplasiaBarrett's esophagusAdenocarcinomaFemalePrecancerous ConditionsModern Pathology
researchProduct

Time pattern of gastric acidity in Barrett's esophagus.

1996

Increased gastroesophageal acid reflux is frequently found in patients with Barrett's esophagus, and it has been hypothesized that gastric acid hypersecretion could be an important factor aggravating the exposure of esophageal mucosa to acid and then contributing to the development of this disorder. The aim of the present study was to assess whether the circadian pattern of gastric acidity differs between refluxer patients with and without Barrett's esophagus and normal subjects. Continuous 24-hr gastric pH monitoring was performed in 119 healthy volunteers, 20 patients with Barrett's esophagus, 37 patients with moderate and 10 patients with severe reflux esophagitis without Barrett's esoph…

Malemedicine.medical_specialtyPhysiologyPopulationGastroenterologyGastric AcidBarrett EsophagusInternal medicinemedicineHumansEsophagusReflux esophagitiseducationEsophagitis PepticMonitoring Physiologiceducation.field_of_studybusiness.industryEsophageal diseaseStomachdigestive oral and skin physiologyGastroenterologyRefluxGastric Acidity DeterminationMiddle Agedmedicine.diseasedigestive system diseasesCircadian Rhythmmedicine.anatomical_structureBarrett's esophagusGastric acidFemalebusinessDigestive diseases and sciences
researchProduct

Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia

2005

Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) has proven to be safe and effective in patients with early neoplasia in Barrett's esophagus. However, long-term results in patients with high-grade intraepithelial neoplasia (HGIN) or with early cancer are still lacking.The aim of the study was to evaluate the efficacy of ALA-PDT and the survival of patients with early Barrett's neoplasia. ALA-PDT was carried out in 66 patients. Protoporphyrin IX induced by oral administration of ALA (60 mg/kg body weight orally applied 4-6 hours before PDT) was used as the photosensitizer. Acid suppression was maintained in all patients.Between September 1996 and September 2002, 667 patients with …

Malemedicine.medical_specialtyTime FactorsEsophageal Neoplasmsmedicine.medical_treatmentPhotodynamic therapyAdenocarcinomaSeverity of Illness IndexGastroenterologyDisease-Free SurvivalBarrett EsophagusGermanyInternal medicineHumansMedicineRadiology Nuclear Medicine and imagingEsophagusSurvival rateAgedNeoplasm StagingRetrospective StudiesIntraepithelial neoplasiaPhotosensitizing Agentsbusiness.industryGastroenterologyCancerAminolevulinic AcidMiddle Agedmedicine.diseaseSurvival RateTreatment Outcomemedicine.anatomical_structurePhotochemotherapyEsophagectomyHigh Grade Intraepithelial NeoplasiaAdenocarcinomaFemalebusinessPrecancerous ConditionsFollow-Up StudiesGastrointestinal Endoscopy
researchProduct

Immunohistochemical/histochemical double staining method in the study of the columnar metaplasia of the oesophagus

2014

Intestinal metaplasia in Barrett’s oesophagus (BO) represents an important risk factor for oesophageal adenocarcinoma. Instead, few and controversial data are reported about the progression risk of columnar-lined oesophagus without intestinal metaplasia (CLO), posing an issue about its clinical management. The aim was to evaluate if some immunophenotypic changes were present in CLO independently of the presence of the goblet cells. We studied a series of oesophageal biopsies from patients with endoscopic finding of columnar metaplasia, by performing some immunohistochemical stainings (CK7, p53, AuroraA) combined with histochemistry (Alcian-blue and Alcian/PAS), with the aim of simultaneousl…

Mild Dysplasiap53MalePathologymedicine.medical_specialtyHistologyEsophageal NeoplasmsBiophysicsSettore MED/08 - Anatomia PatologicaBiologyAdenocarcinomadigestive systemBarrett EsophagusEsophagusAntigenMetaplasiamedicineHumansEsophaguslcsh:QH301-705.5Retrospective StudiesMetaplasiaStaining and LabelingBrief ReportBarrett’s oesophagusIntestinal metaplasiaCell Biologymedicine.diseaseImmunohistochemistryEpitheliumdigestive system diseasesBarrett’s oesophagus columnar-lined oesophagus p53 Aurora A kinasemedicine.anatomical_structureBarrett’s oesophagus columnar-lined oesophagus p53 Aurora A kinase.lcsh:Biology (General)columnar-lined oesophagusAdenocarcinomaImmunohistochemistryAurora A kinaseFemaleGoblet Cellsmedicine.symptomEuropean Journal of Histochemistry
researchProduct

Prognostic significance of tumor ploidy and histomorphological parameters in adenocarcinoma of Barrett's esophagus.

1999

<i>Background:</i> Despite recent advances in surgical and multidisciplinary treatment, the prognosis for patients with adenocarcinoma of Barrett’s esophagus remains poor. The low prognostic accuracy of even surgical pathologic TNM staging suggests that additonal parameters are necessary in determining the prognosis. <i>Method:</i> In a retrospective analysis of 50 patients who underwent transhiatal or transthoracic esophageal resection due to adenocarcinoma of Barrett’s esophagus, a quantitative DNA analysis using image cytometry was performed in addition to the TNM classification and usual morphological criteria. At the time of DNA analysis the histomorphological p…

OncologyMalemedicine.medical_specialtyEsophageal NeoplasmsAdenocarcinomaGastroenterologyBarrett EsophagusEsophagusInternal medicinemedicineHumansEsophagusDna ploidyImage CytometryProportional Hazards ModelsRetrospective StudiesPloidiesProportional hazards modelbusiness.industryGastroenterologyRetrospective cohort studyDNA Neoplasmmedicine.diseasePrognosisdigestive system diseasesmedicine.anatomical_structureBarrett's esophagusAdenocarcinomaImage CytometrySurgeryFemalePloidybusinessDigestive surgery
researchProduct

CD1a: a novel biomarker for Barrett's metaplasia?

2003

educational book. Alexandria: American Society for Clinical Oncology, 2001: 226–44. 49 Hussain M, Smith DC, Al-Sukhun S, et al. Preliminary results of HER-2/neu screening and treatment with trastuzumab (Herceptin) (T), paclitaxel (P), carboplatin (C) and gemcitabine (G) in patients with advanced urothelial cancer. Proc Am Soc Clin Oncol 2002; 21: 800a. 50 Al-Sukhun S, Hussain M. Current understanding of the biology of advanced bladder cancer. Cancer 2003; 97 (8 suppl): 2064–75. 51 Hussain SA, Ganesan R, Hiller L, et al. Pro-apoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder. Br J Cancer 2003; 88: 586–92. 52 Stein JP, Ginsberg DA, Grossfiel…

Oncologymedicine.medical_specialtyBladder cancerbusiness.industrymedicine.medical_treatmentCancermedicine.diseaseCarboplatinGemcitabineRadiation therapyAntigens CD1chemistry.chemical_compoundBarrett EsophagusTransitional cell carcinomaOncologychemistryPaclitaxelTrastuzumabInternal medicinemedicineHumansOncology CD1abusinessBiomarkersmedicine.drug
researchProduct